Curcumin has been shown to possess potent chemopreventive and antitumor effects on prostate cancer. However, the molecular mechanism involved in curcumin's ability to suppress prostate cancer cell invasion, tumor growth and metastasis is not yet well understood. In this study, we showed that curcumin can suppress EGF-and heregulin-stimulated PC-3 cell invasion, as well as androgen-induced LNCaP cell invasion. Curcumin treatment significantly resulted in reduced MMP-9 activity and down-regulation of cellular matriptase, a membrane-anchored serine protease with oncogenic roles in tumor formation and invasion. Our data further show that curcumin is able to inhibit the induction effects of androgens and EGF on matriptase activation, as well as to reduce the activated levels of matriptase after its overexpression, thus suggesting that curcumin may interrupt diverse signal pathways to block the protease. Furthermore, the reduction of activated matriptase in cells by curcumin was also partly due to curcumin's effect Author Manuscript Published OnlineFirst on March 6, 2013; DOI: 10.1158/1940 model, curcumin not only inhibits PCa tumor growth and metastasis but also down-regulates matriptase activity in vivo. Overall, the data indicate that curcumin exhibits a suppressive effect on prostate cancer cell invasion, tumor growth and metastasis, at least in part via down-regulating matriptase function.
Introduction
Prostate cancer (PCa) is currently the second leading cause of cancer-related death in men in the western world (1) . Localized PCa is highly curable by surgery or chemotherapy to remove or destroy the cancerous lesions. Yet, there currently exist no efficacious therapies for advanced PCa with hormone refractory or metastatic phenotypes (2) . Therefore, it is a critical issue to discover a chemical or compound valuable for developing new therapies that inhibit the progression or invasive abilities of PCa.
It has been shown that the expression levels of matriptase, a membrane-anchored serine protease, are increased in PCa and correlated with tumor grades and poor prognosis (3) . Several agents including androgens, EGF, sphingosine 1-phosphate and suramin exhibit stimulatory effects on the matriptase activation in mammalian epithelial, prostate and breast cancer cells (4) (5) (6) . In matriptase transgenic mice, matriptase overexpression promoted tumorigenecity and carcinogen-induced tumor formation (7) . Matriptase is also involved in ErbB-2-induced PCa cell invasion (6) . be an opportunity to reduce prostate tumor growth and progression (8) . Thus, matriptase may present a new potential target for PCa therapies.
Curcumin has emerged as a compound with multiple biological properties for health maintenance and cancer prevention. The anti-inflammatory and anti-oxidant activities of curcumin have been proposed via inhibiting NF-κB, COX-2, iNOS and cytokine production (9, 10) . In rodents, curcumin can prevent carcinogenesis induced by various carcinogens (11) . A more recent phase II clinical study has pointed out that allotting low concentrations of curcumin in patients has a similar biological impact on NF-țB, COX-2 and phospho-STAT-3 in peripheral blood mononuclear cells, as those observed in the in vitro studies with 5-50 μM of curcumin treatments (12, 13) . In hepatocellular cancer cells, curcumin can inhibit cancer cell invasion and MMP-9 secretion (14) . In PCa cells, curcumin can down-regulate androgen receptors (10, 15) , decrease cell proliferation (16) , and inhibit DU145 cell invasion via decreasing MMP-2/-9 activity (17) . However, the more detailed molecular mechanisms how curcumin inhibits PCa cell invasion, tumor growth and metastasis have not been yet clearly elucidated. In this study, we show that curcumin can significantly suppress 
Materials and Methods
Materials-DMEM, FBS, and RPMI1640 media were obtained from Hyclone (Logan, UT). Protein Assay kits were from Bio-Rad (Hercules, CA). Anti-V5 Ab and Lipofectamine TM 2000 reagent were purchased from Invitrogen (Carlsbad, CA).
Curcumin (Cat.# C7727, purity 94% curcuminoid, 80% curcumin) and all other reagents were purchased from Sigma-Aldrich, MO, unless otherwise noted. M24, M69 and M19 antibodies were gifts from Dr. Chen-Yong Lin at the Georgetown University, DC.
Cell culture-PC-3, CWR22Rv1 and WPMY-1 cells were obtained from ATCC.
PNT-2 cells were purchased from Sigma-Aldrich. PC-3 and WPMY-1 cells were maintained in DMEM containing 10% FBS and 2 mM glutamine in a 5% CO 2 , 37°C
incubator. DU145, C-33 and C-81 LNCaP cells were gifts from Dr. Ming-Fong Lin at the University of Nebraska Medical Center, NE. CWR22Rv1, C-33 and C-81 LNCaP, DU145 and PNT-2 cells were maintained in 5% FBS, 2 mM glutamine RPMI1640 medium. No authentication for all cell lines used was done by the authors.
Cell growth and cytotoxicity assays-Cells were seeded at a density of 1.5x10 4 For cell cytotoxicity assay, one day after seeding, cells were treated with indicated concentrations of curcumin for 16 hours and the viable cell numbers were counted by a hemacytometer with a trypan blue exclusion method.
Cell invasion and migration assays-Transwell assays were performed according to the previously described procedures (18) . In brief, transwells were coated with or without 20 ȝg of matrigel (BD biosciences, NJ) for cell invasion or migration assay. Serum-starved cells were then seeded at a density of 3x10 5 Western blot analysis-For western blotting by M24, M69 and M19 mAbs, equal amounts of cell lysates were mixed with protein loading dye in a non-reducing and non-boiling condition (20) . For the other samples, equal amounts of cell lysates were mixed with regular protein loading dye and boiled for 10 minutes. Samples were separated by SDS-PAGE and transferred to nitrocellular membranes (Whatman, Piscataway, NJ). The membranes were blocked with 5% skim milk in TBST at RT for 1 hour and then incubated with primary antibodies at 4°C overnight, followed by secondary antibody incubation. The protein images were visualized using an Enhanced Luminol Reagent Plus (Perkin Elmer, PA) and detected by a luminescent image analyzer (LAS-4000; Fujifilm, Japan). 
Tumor xenografts and bioluminescence analysis-

Results
Curcumin Inhibition of Prostate Cancer Cell Migration and Invasion
To examine the effects of curcumin on the growth of PC-3 cells, and ensure that the cell growth kept in the log phase after 5-day culture, cells were seeded at a density of 1.5x10 4 cells/cm 2 and treated with 5, 25 and 50 ȝM of curcumin. With MTT assays, Figure 1A showed that curcumin ably inhibited PC-3 cell growth in a time-and dose-dependent manner. We then tested the cytotoxicity of curcumin on PC-3 cells in a cell density of 3x10 5 cells/cm 2 , because this cell density would be used in following transwell assays. Using trypan blue exclusion assays, the results displayed that there was no significant cytotoxicity on PC-3 cells after the curcumin treatment (Fig. 1B) .
That 25 or 50 ȝM of curcumin dramatically decreased PC3 cell growth without any significant effect on cell cytotoxicity may be partly due to the difference of cell-seeding density and/or the inhibitory effect of curcumin on dehydrogenases (21).
To further investigate the effect of curcumin on PCa cell migration and invasion, we performed transwell assays and found that the migration and invasion of PC-3 cells were significantly decreased by approximately 50% after 5 μM-curcumin treatment and suppressed up to 80% upon 25 and 50 μM curcumin treatments ( Fig. 1C and 1D ). 
Identification of Matriptase as a Curcumin-targeting Serine Protease in PCa Cells
It has been shown that both matrix metalloproteinases (MMPs) and serine proteases play important roles in cancer cell invasion (23, 24) . To further explore the Since the expression of matriptase has been shown to be correlated with the PCa progression (3) and also that matriptase is involved in ErbB-2-induced PCa cell invasion (6), we then proposed that matriptase was a curcumin-targeting serine protease in PCa cells, by examining the effect of curcumin on matriptase using was further validated by the western blotting with M69 Ab. Additionally, the protein levels of HAI-1 or in a complex with activated matriptase were also reduced by curcumin. To further assess the effect of curcumin on the transcription levels of matriptase and HAI-1, we performed Q-PCR and showed that curcumin had no significant effect on the expression of both genes (Fig. 2D) . Thus, the data indicate that the reduction of matriptase and HAI-1 protein levels by curcumin is not via transcription regulation, but may utilize a post-translational mechanism for decreasing cellular matriptase.
Since epithelial-mesenchymal transitions (EMT) have been shown to be implicated in the PCa progression (25), we then investigated if curcumin functioned as an antogonist for EMT to reduce PCa cell invasion, by using the immunoblotting analyses of several EMT markers including E-cadherin, β-catenin, vimentin and snail. (Fig. 2G) . Thus, the data indicate that curcumin exhibits an inhibitory role in matriptase in PCa cells, with a less effect on prostatic epithelial PNT2 cells. 
In addition, we examined the effects of two curcumin analogues, dimethoxycurcumin (DMC) and EF24, on matriptase in PC3 cells and found that both analogues also can reduce the activated levels of matriptase (Fig. 2H) . Taken together, these data suggest that curcumin-decreased PCa cell invasion is at least partly due to decreasing both MMP-9 activity and cellular matriptase, rather than altering the EMT process.
Curcumin-reduced Matriptase Function in PC-3 Cells
Next we examined the pretreatment effect of curcumin on the FBS-induced matriptase activation in PCa cells. The data showed that the pretreatment of curcumin dramatically depressed the stimulatory effects of FBS on matriptase activation ( Fig   3A) . To further evaluate the duration of curcumin on reducing cellular matriptase in PCa cells, the effect of 1-hour acute curcumin treatment on matriptase was examined.
The data showed that curcumin could decrease the activated matriptase up to 8 hours after the acute treatment (Fig. 3B) . Four hours after the acute treatment, the decreased levels of latent matriptase began to rebound. We then analyzed the effect of the acute curcumin treatment on PCa cell invasion and found that the acute treatments of 25 and 50 ȝM curcumin suppressed PC3 cell invasion by ~50 % and ~64 % (Fig. 3C) 
Curcumin Promotion of Matriptase Shedding and Suppression of
Matriptase-induced PCa Cell Invasion
The shedding of matriptase-HAI-1 complexes to extracellular environments is thought of as a mechanism to remove matriptase from cells (26) . Since Figure 2 shows that curcumin can reduce the cellular content of matriptase but has no effect on the gene expression, we accordingly examined whether curcumin could promote the shedding of matriptase, leading to decreasing cellular matriptase in PCa cells. The effect of curcumin on matriptase shedding was examined by using western blotting to analyze the shed matriptase in the conditioned media. The data revealed that curcumin promoted the shedding of the matriptas-HAI-1 complex in a dose-dependent manner, with less effect on the latent form of matriptase (Fig. 4A) . We then further analyzed whether the shed matriptase in the conditioned media retains its function for cancer cell invasion. Following the curcumin treatment, the conditioned media were collected, washed out of curcumin and used to treat PC-3 cells. Through cell invasion assays, the data showed that the shed matriptase had no significant effect on PCa cell invasion (Fig. 4B) .
Moreover, to recaptulate the increased levels of matriptase in advanced PCa, Since matriptase overexpression is observed in a variety of human carcinomas including PCa (3, 27), we further examined the role of matriptase in PCa cell invasion and the effect of curcumin on matriptase-induced cancer malignancy by establishing stable pools of matriptase-overexpressing CWR22Rv1 cells. The data displayed that the total and activated levels of matriptase increased in matriptase-overexpressing CWR22Rv1 cells (Fig. 4D ), which were concurrent with increased invasion capabilities (Fig. 4E) . We then examined the effect of curcumin and AEBSF on the invasion of matriptase-overexpressing CWR22Rv1 cells. As shown in up to 80%, down to the levels of curcumin-treated control cells. Thus, the data denote that curcumin exhibits a strong inhibitory potential for PCa cell invasion, especially that caused by matriptase overexpression or dysregulation.
Curcumin-inhibited Tumor Growth and Metastasis in a PCa Xenograft Model
To further assess if curcumin can inhibit prostate tumor growth and metastasis, we examined the effects of curcumin on the tumor growth of PC3-Luc cells using a xenograft model. As shown in Fig. 5A , there was a significant regression of tumor volume in the group of mice receiving the curcumin treatment. No animal body weight was significantly altered during the treatment, indicating that the curcumin treatment had no toxicity in mice (Fig. 5B) . After scarification, the tumor mass was measured and significantly reduced in the group of curcumin-treated mice (Fig. 5C ).
Moreover, we checked if there was any metastatic nodule in the lymph nodes nearby the xenografted tumors, and found that curcumin treatment significantly reduced the metastatic lesions at brachial lymph nodes in the xenografted mice, indicating that curcumin exhibited an inhibition effect on PCa metastasis (Fig. 5D) . We then further 
curcumin on PCa cell invasion, implying that some serine protease(s) was curcumin-targeting and involved in promoting PCa cell invasion. In PCa, ErbB-2 is overexpressed in approximately 80% of metastasized PCa lesions (29) and matriptase is involved in ErbB-2-induced PCa cell invasion (6) . These previous findings inspired us to explore whether matriptase can promote PCa cell invasion and if curcumin can inhibit matriptase-induced PCa cell invasion. Interestingly, our data revealed that matriptase overexpression can induce PCa cell invasion, suggesting that the dysregulation of matriptase is a factor in allowing cancer cells to obtain high invasion capabilities during the PCa progression. Comparatively, our data further suggest that curcumin can inhibit matriptase-induced PCa cell invasion through reducing the cellular matriptase. In addition, curcumin also can inhibit prostate tumor growth and metastasis, at least partly via down-regulating the level of activated matriptase in PCa xenografted tumors (Fig. 5) . Thus, curcumin exhibits a chemopreventive and therapeutic potential in matriptase-involved PCa malignancy.
As shown in Fig. 6 , matriptase function is mainly regulated by three steps: 
curcumin may block the androgen-and ErbB ligand-induced signal pathways for matriptase activation, leading to reducing PCa cell invasion. In conclusion, the data suggest that curcumin may be a potent phytocomponent able to efficiently inhibit matriptase-mediated PCa malignancy.
The inhibitory effects on the activated matriptase in PCa cells after an acute curcumin treatment only last up to 16 hours. This may be due to curcumin consumption by the cells or the instability of curcumin in the culture medium, since curcumin has been shown to be unstable at neutral and basic pH and decomposed approximately by 50% in the culture medium after 8-hour incubation (34) . Therefore, two curcumin analogs (DMC and EF24) with an enhanced metabolic stability and a higher potency than curcumin (35, 36) were used in this study and show both analogs also can reduce the cellular levels of activated matriptase in PCa cells. Thus, this study points out that enhancing the stability and potency of curcumin will improve the efficiency of curcumin in the chemoprevention or cancer therapy, especially in cancers with matriptase dysfunction.
Curcumin has been shown to down-regulate urokinase-type plasminogen activator (uPA) in PCa cells (37) . Pro-uPA has been shown to be one of matriptase substrates (38, 39) . Consequently, curcumin's ability to inhibit the activities of uPA may be partly attributed to its inhibitory effects on matriptase.
In conclusion, our data reveal that matriptase can be activated by multiple factors, including its overexpression, growth factors or androgens, and ultimately lead to PCa cell invasion. Curcumin can significantly decrease the cellular levels of matriptase in PCa cells, by promoting protease shedding. Therefore, this study provides a novel mechanism for establishing how curcumin can inhibit PCa cell invasion, tumor growth and metastasis by the down regulation of matriptase function. 
